RFICs

WHITE PAPERS AND CASE STUDIES

• How A Leading CDMO Reduced Yield Variability With Automation

  Explore the transformative journey of a leading CDMO company and how they adopted an innovative platform that enhances data analytics and drives pharmaceutical manufacturing advancements.

• A Streamlined Biopharmaceutical Isolator Solution

  This custom-designed, eight-foot isolator helped a client meet their decontamination needs, maintaining ISO-5 sterile conditions while decreasing turn-around time for filling small batches.

• Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies

  To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.

• Propelling Glioblastoma Research: Orthotopic Model Solutions

  Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

• Diagnosing COVID-19 And Other Infectious Diseases In Remote Locations

  Learn about the cutting-edge mobile BSL-3 laboratory that was custom-built in response to a need for a flexible diagnostic testing solution in the United Arab Emirates due to a surge in COVID-19 cases.

• What The Hidden Springs Pilot Case Study Reveals About Cutting-Edge Water Treatment

  A seven-month pilot study shows how ozone treatment reduced hydrogen sulfide and TOC at the Hidden Springs Water Treatment Facility, improving water quality and validating a scalable alternative.

• eSource For A COVID Treatment Trial

  Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.

• Designing, Developing, And Validating A Precision Extruded Tube In Just 8 Weeks

  A multinational medical device company worked to redesign an introducer sheath for a neurovascular microcatheter. After successful prototypes, the design was completed in 8 weeks.

• Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer

  This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.

• Using eConsent Data To Populate Site And Sponsor Data Systems

  A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

• FSP Models For IVD Clinical Trials: Meeting Growing Pipeline Demands

  Uncover how a mid-sized genetic testing and diagnostics company navigated the challenges of conducting clinical trials with limited resources and an expanding product portfolio.

• RTSM: Randomization And Cohort Management, IP Inventory Management

  Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.